Familial ALS Development Traced to Mutations in Newly Identified Gene, NEK-1

German researchers have identified a new gene — called NEK1 — that appears to be responsible for familial amyotrophic lateral sclerosis (ALS). Loss of function mutations in the gene were more common in ALS patients than in healthy controls, according to findings published in the journal Brain. Familial ALS…

Jen and Pat Quinn, alumni from Iona College, were distinguished during the halftime at the Iona College Men’s basketball game versus Quinnipiac for their fight against amyotrophic lateral sclerosis (ALS).  Video by SALRADIO. Learn more about ALS here: https://bit.ly/1RmVMwo…

In this video by ALS Society of Canada, meet Dr. Michael Strong, a pioneer in ALS research with more than 20 years’ experience. Watch him comment on where your donated dollars go in research and the achievements of his lab at Western University. Learn more about ALS…

Last week’s hot topic on ALS was an article titled Biohaven’s ALS Drug Candidate BHV-0223 Receives Positive FDA Feedback written by Magdalena Kegel. The article is focused on the recently announcement that Portage Biotech and Biohaven Pharmaceuticals  have received positive feedback from the U.S.

https://www.youtube.com/watch?v=iGZxxppCVbM In this video by the Motor Neurone Disease Association, meet Alistair the Optimist. Learn more about ALS here: https://bit.ly/ALSNewsToday…

In this video by Matthew Moore learn more about Steve’s ALS Fight. Learn more about ALS here: https://bit.ly/ALSNewsToday  …

In this video by the Motor Neurone Disease Association, meet “Mark Maddox, the soccer player who made 300 appearances for Altrincham FC and now has motor neurone disease (MND).” Learn more about ALS here: https://bit.ly/ALSNewsToday…

Portage Biotech and Biohaven Pharmaceuticals recently announced they have received positive feedback from the U.S. Food and Drug Administration (FDA) on their Pre-Investigational New Drug Application (PIND) interaction regarding Biohaven’s investigative drug BHV-0223, intended for treatment of amyotrophic lateral sclerosis (ALS). BHV-0223 is the glutamate modulating compound riluzole, contained in the tablet…